why am i not losing weight in semaglutide 5 Reasons You Are on and How WithCare Clinic Can Help Not Losing Weight on Semaglutide?

GLP-1 medication safety concerns in patients with breast cancer There is limited data on the safety of GLP-1 agonists in cancer patients, especially those who are undergoing treatment

According to a press release from WW, with this acquisition, the company will be able to provide the support needed to help people build livable healthy habits for the long term and manage the dietary-induced side effects often felt while taking chronic weight management medications, such as glucagon-like peptide-1s (GLP-1s). CEO and Co-founder of Sequence stated in the press release that pairing behavior change with medically appropriate clinical solutions is more powerful and more sustainable than clinical alone. So it is likely that we will see WW offering semaglutide in the future

What this means in practice: compounded GLP-1 medications may carry risks that differ from those of FDA-approved branded products

Tinsley GM, Heymsfield SB